We next used other selective C5aR1 inhibitors, JPE-1375 and Avacopan [55, 56], and found that both of these showed more significant effects on cancer cell viability than PMX205 (Fig. 4B and Supplementary Fig. 4B). Here, C5AR1 is linked to cancer.